Photo: Depositphotos
May 2, 2025, 09:14
ESMO Open – Tumor-Informed ctDNA Assay for Recurrence Prediction in Locally Advanced SCCHN
ESMO Open posted on X:
“Tumor-informed ctDNA assay to predict recurrence in locally advanced squamous-cell carcinoma of the head and neck (SCCHN) in ESMO Open. Personalized ctDNA dynamic evaluation is feasible and had prognostic significance in pts with LA-SCCHN.”
Title: Tumor-informed ctDNA assay to predict recurrence in locally advanced squamous-cell carcinoma of the head and neck (SCCHN)
Authors: N. Honoré, G. Laliotis, V. Aushev, S. Velichko, C. Palsuledesai, H. Dahou, C. van Marcke, R. Galot, M. Liu, J.-P.H. Machiels
Read The Full Article at ESMO Open.
Read more posts featuring Head and Neck Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 30, 2025, 23:58
May 30, 2025, 20:19
May 30, 2025, 19:00